PRESS RELEASE published on 01/13/2025 at 18:00, 1 year 5 months ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
BRIEF published on 01/06/2025 at 18:05, 1 year 5 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 5 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
BRIEF published on 01/03/2025 at 18:05, 1 year 5 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 5 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
BRIEF published on 12/31/2024 at 18:05, 1 year 5 months ago Oxurion Postpones Strategic Transaction Due to Ongoing Discussions Report Strategic Transaction Oxurion Leuven Financial Discussions
PRESS RELEASE published on 12/31/2024 at 18:00, 1 year 5 months ago Oxurion Announces Postponement of Signing for Strategic Transaction Due to Ongoing Discussions Oxurion NV announces a short postponement of approximately four weeks for the signing of its strategic transaction due to better than expected financial results of the target. Parties are committed to finalizing the agreement as a key priority Financial Results Commitment Postponement Strategic Transaction Oxurion NV
Published on 06/19/2026 at 04:30, 3 hours 47 minutes ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 6 hours 57 minutes ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/19/2026 at 01:07, 7 hours 10 minutes ago Usha Resources Announces Share Issuance in Payment of Debenture Interest, Adopts Semi-Annual Reporting
Published on 06/19/2026 at 00:00, 8 hours 17 minutes ago Redwood AI Announces Initiation of Chemical Risk Assessment Module
Published on 06/19/2026 at 08:00, 17 minutes ago Mutares has signed an agreement to acquire Synthomer a.s. from Synthomer plc to grow further the Chemicals & Materials segment
Published on 06/19/2026 at 07:25, 51 minutes ago DFSK Accelerates Global Expansion with Debut of the Right-Hand-Drive E5 PLUS in Hong Kong
Published on 06/19/2026 at 07:00, 1 hour 17 minutes ago HORNBACH Group delivers strong start to new financial year – net sales up 4.9% in Q1 2026/27
Published on 06/18/2026 at 18:00, 14 hours 17 minutes ago Outstanding shares and voting rights statement at 31 May 2026
Published on 06/18/2026 at 17:45, 14 hours 32 minutes ago EURAZEO INVESTS IN LAURALU, A PAN-EUROPEAN PROVIDER OF DEPLOYABLE INDUSTRIAL INFRASTRUCTURE
Published on 06/18/2026 at 17:38, 14 hours 38 minutes ago Statement of transactions in own shares from June 8, 2026 to June 12, 2026
Published on 06/18/2026 at 09:06, 23 hours 10 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany